Datamatics assists UTI mutual fund amid pandemic to set-up paperless digital workplace
Datamatics assists UTI mutual fund amid pandemic to set-up paperless digital workplace

Datamatics assists UTI mutual fund amid pandemic to set-up paperless digital workplace

Shreya Chaware Article rating: 5.0

Datamatics Global Services on Thursday announced that it has successfully implemented its digital workspace solution for UTI mutual fund, which involves digitising two of its critical processes to achieve a seamless flow of information, higher transparency, and agility across multiple offices.  

Five stocks with selling interest
Five stocks with selling interest

Five stocks with selling interest

Ganesh Pawar Article rating: 4.2

The market opened in red on January 14, 2021, overall volumes in futures & options currently stand at 4,69,71,641 contracts with a turnover of Rs. 42,98,484.52 crore.

Five stocks with buying interest
Five stocks with buying interest

Five stocks with buying interest

Ganesh Pawar Article rating: 3.2

The market opened in red on January 14, 2021, overall volumes in futures & options currently stand at 4,69,71,641 contracts with a turnover of Rs. 42,98,484.52 crore.

Equity MF in 2020
Equity MF in 2020

Equity MF in 2020

Shashikant Singh Article rating: 5.0

The year ended with an equity AUM of Rs 9.5 lakh crore. This is the seventh consecutive year in which the equity AUM has increased.  

Unichem Laboratories gets USFDA approval for Celecoxib capsules
Unichem Laboratories gets USFDA approval for Celecoxib capsules

Unichem Laboratories gets USFDA approval for Celecoxib capsules

Anthony Fernandes Article rating: 5.0

On Wednesday, Unichem Laboratories Limited announced that it has received an abbreviated new drug application (ANDA) approval for its Celecoxib capsules 50 mg, 100 mg, 200 mg & 400 mg from United States Food & Drug Administration (USFDA). 

RSS
First24892490249124922494249624972498Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR